Cemtrex Inc. (CETX) Receives $1M Order for Security Technology System
Brooklyn, NY, July 13, 2020 (GLOBE NEWSWIRE) — – Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading multi-industry technology company […]
TSX News -
Globex Vends Some Specialty Mineral Assets To Electric Royalties Ltd.
ROUYN-NORANDA, Quebec, July 13, 2020 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, […]
Magna Terra Update on the Acquisition of ExploreCo and Oversubscribed Concurrent Financing
TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — Magna Terra Minerals Inc. (the “Company” or “Magna Terra”) (TSX-V: MTT) is pleased […]
Westhaven Reports on Reason for Halt in Trading
VANCOUVER, British Columbia, July 13, 2020 (GLOBE NEWSWIRE) — Westhaven Gold Corp. (TSX-V:WHN) reports that the halt in the trading […]
Benefits of Stereotaxis Robotic Technology in COVID-19 Patient Highlighted in Publication
ST. LOUIS, July 13, 2020 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the […]
Shaw Encourages Community to #ChipinforKids to Drive Support for Shaw Charity Classic Charitable Beneficiaries
CALGARY, Alberta, July 13, 2020 (GLOBE NEWSWIRE) — Shaw Communications Inc. is encouraging the community to #ChipinforKids this summer in […]
Chicken Soup for the Soul Entertainment Announces Pricing of $21 Million of Notes Due 2025
COS COB, Conn., July 13, 2020 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE) (the “Company”), […]
Castor Maritime Inc. Announces Pricing of $17.3 Million Registered Direct Offering
LIMASSOL, Cyprus, July 13, 2020 (GLOBE NEWSWIRE) — Castor Maritime Inc. (the “Company”) (NASDAQ: CTRM) announced today that it has […]
OPES Acquisition Corp.’s Merger Target Proves America Is Hungrier Than Ever As BurgerFi Generates Significant Growth In Delivery Dining
– The Better Burger Concept’s Delivery Numbers Rise Amid Nation’s Pandemic –NEW YORK and PALM BEACH, Fla., July 13, 2020 […]
Avalon GloboCare Provides Updates on its Lead Scientific and Clinical Programs in CAR T-Cell Therapy and COVID-19
Completed Phase I Clinical Study of 4-1BB Based Anti-CD19 CAR-T Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia; Achieved 90% Complete […]
